Gyre Therapeutics, Inc. GYRE US Equity
$6.59
-0.09 (-1.35%)
USD · as of 2026-08-28 · marketstack
Gyre Therapeutics, Inc. (Nasdaq: GYRE), an SEC filer in Pharmaceutical Preparations, closed at $6.59, -1.3%, on 2026-08-28, with a market cap of $745M as of 2026-08-27, a trailing P/E of 334.0, a return on equity of 11.7%, a net margin of 8.5% and 3-year sales growth of 4.5%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-08-26 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-08-07 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-07-16 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-07-16 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2026-07-15 | 8-K 2.02 | Results of operations and financial condition (earnings) (amendment)earnings history (EARN) → | sec.gov ↗ |
Source: SEC EDGAR (public domain) · history starts 2026-07-15
Every row is a filed document, checked against its EDGAR index.